GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $426,000 | +0.5% | 9,778 | +0.3% | 0.00% | +33.3% |
| Q1 2022 | $424,000 | +51.4% | 9,745 | +53.2% | 0.00% | +50.0% |
| Q4 2021 | $280,000 | +19.1% | 6,360 | +3.6% | 0.00% | +100.0% |
| Q3 2021 | $235,000 | -4.1% | 6,141 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $245,000 | +7.5% | 6,141 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $228,000 | -27.2% | 6,392 | -25.0% | 0.00% | -50.0% |
| Q4 2020 | $313,000 | -1.3% | 8,518 | +1.2% | 0.00% | 0.0% |
| Q3 2020 | $317,000 | -11.7% | 8,419 | -4.4% | 0.00% | -33.3% |
| Q2 2020 | $359,000 | +44.8% | 8,806 | +34.5% | 0.00% | +50.0% |
| Q1 2020 | $248,000 | -54.0% | 6,548 | -42.9% | 0.00% | -33.3% |
| Q4 2019 | $539,000 | +44.9% | 11,474 | +31.5% | 0.00% | +50.0% |
| Q3 2019 | $372,000 | -32.7% | 8,727 | -36.9% | 0.00% | -50.0% |
| Q2 2019 | $553,000 | +7.0% | 13,825 | +11.8% | 0.00% | 0.0% |
| Q1 2019 | $517,000 | +115.4% | 12,370 | +96.9% | 0.00% | +100.0% |
| Q4 2018 | $240,000 | -10.4% | 6,281 | -6.0% | 0.00% | 0.0% |
| Q3 2018 | $268,000 | +1.5% | 6,681 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $264,000 | -7.7% | 6,541 | -10.5% | 0.00% | 0.0% |
| Q1 2018 | $286,000 | +10.4% | 7,309 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $259,000 | -12.8% | 7,309 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $297,000 | -5.7% | 7,309 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $315,000 | +2.3% | 7,309 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $308,000 | +9.2% | 7,309 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $282,000 | -10.5% | 7,334 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $315,000 | -5.1% | 7,309 | -4.6% | 0.00% | 0.0% |
| Q2 2016 | $332,000 | +9.2% | 7,659 | +2.0% | 0.00% | 0.0% |
| Q1 2016 | $304,000 | +0.3% | 7,509 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $303,000 | -8.5% | 7,509 | -12.8% | 0.00% | 0.0% |
| Q3 2015 | $331,000 | -6.5% | 8,616 | +1.4% | 0.00% | 0.0% |
| Q2 2015 | $354,000 | -37.2% | 8,497 | -30.5% | 0.00% | -33.3% |
| Q1 2015 | $564,000 | +18.7% | 12,220 | +9.9% | 0.00% | +50.0% |
| Q4 2014 | $475,000 | -14.1% | 11,120 | -7.6% | 0.00% | 0.0% |
| Q3 2014 | $553,000 | -7.7% | 12,034 | +7.5% | 0.00% | 0.0% |
| Q2 2014 | $599,000 | +20.3% | 11,195 | +20.1% | 0.00% | 0.0% |
| Q1 2014 | $498,000 | +5.7% | 9,321 | +5.7% | 0.00% | 0.0% |
| Q4 2013 | $471,000 | +5.1% | 8,821 | -1.1% | 0.00% | 0.0% |
| Q3 2013 | $448,000 | -40.8% | 8,921 | -41.1% | 0.00% | -50.0% |
| Q2 2013 | $757,000 | +49.9% | 15,152 | +40.9% | 0.00% | +33.3% |
| Q1 2013 | $505,000 | – | 10,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |